Insights

We’re thrilled to be a part of the CGT Catapult, working with 20 brilliant companies to accelerate the technology development for cell and gene therapy manufacturing. 

With the world becoming increasingly impatient for a great sustainability reset, last week’s inaugural Rethinking Materials Virtual Summit did a pretty decent job at starting to shape the agenda for innovation in plastics and packaging over the next five or so years.

Watch our webinar to discover how deep learning is allowing us to design optimized protein sequences to perform beyond those found in nature.

Scale-down models have become a popular development tool, especially in the bioprocessing industry. But how do you make them robust and reproducible?

Diagnosing cancer early to treat it more effectively is vital. Here, Josh Gibson, senior physicist at Cambridge Consultants, unveils a potentially life-saving breakthrough in the field of liquid biopsy that’s been hailed by a leading innovation award jury…

The past year has seen an unprecedented acceleration of innovation in the diagnostics space. Reflecting on the virtual themes and debates at Molecular Med Tri-Con 2021, Head of Life Sciences Symon Cotton says that the speed of tests and vaccines coming to market is not having an adverse effect on quality. Medical developments can be safely delivered to quicker timescales...

Symon Cotton, Head of Life Sciences at Cambridge Consultants, attended this year’s Society for Laboratory Automation and Screening conference, SLAS2021. Even in virtual form, the speakers dazzled with fresh and exciting ideas for the future of patient treatments.

The rapid, at home COVID-19 antigen test from digital diagnostics company Ellume features core technology from Cambridge Consultants. Read how this FDA approved test is set to be a game-changer in the global pandemic.

We are delighted to report a significant step forward as we grow our bioinnovation capability as we have received our licence from the UK Human Tissue Authority to store human tissue for research purposes. This opens the way to future development in cell therapies and regenerative medicine. 

Symon Cotton explores the use of pooled testing techniques for deploying mass Covid testing.  

James Hallinan's takeaway from SynBioBeta 2020: Synbio is growing up and getting ever more relevant to the everyday. 

This paper highlights macro and micro factors affecting oncology and proposes a partnership-driven framework to catalyze innovation for oncology-focused biopharma – as well as the role that select high-impact technologies will have on the on the entire value-chain of cancer research and care delivery.